5-fu therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer
5-fu therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer"
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
ABSTRACT This 4 year study reports on a pharmacokinetic study for the widely used regimen of cis-platin plus continuous 5-day 5-FU as first-line chemotherapy of head and neck cancer, and the
benefit of such data for real-time therapy management. Pharmacokinetic analysis of 177 cycles for 77 patients from a group of 89 patients (group 1; 228 cycles) revealed that both the
time-concentration product (AUC) for the entire cycle and the half-cycle AUC (AUC0-3 days) were predictive of cycle toxicity. Real-time analysis of individual AUC0-3 days was used to decide
whether to reduce the dose during the second half of the cycle for a total of 249 cycles (81 patients; group 2). The dose in the second half of the course was reduced in 40% of the group 2
courses. There was a statistical difference in complete response rates between group 1 (31%) and group 2 (47%), (0.02 less than P less than 0.05) and a statistically significant reduction
was observed in the incidence of toxic cycles (greater than grade 2, group 1 = 20% versus group 2 = 12.4%; 0.02 less than P less than 0.05). Pharmacokinetic follow-up of these patients has
proved to be an objective means to improve therapeutic index significantly. Access through your institution Buy or subscribe This is a preview of subscription content, access via your
institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 24 print issues and online access $259.00 per year only $10.79 per issue Learn more Buy this
article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in
* Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS A RANDOMIZED PHASE 3 TRIAL OF GEMCITABINE OR NAB-PACLITAXEL
COMBINED WITH CISPLATIN AS FIRST-LINE TREATMENT IN PATIENTS WITH METASTATIC TRIPLE-NEGATIVE BREAST CANCER Article Open access 12 July 2022 INTRAVENOUS LIPOSOMAL IRINOTECAN IN METASTATIC
TRIPLE-NEGATIVE BREAST CANCER AFTER ≥ 2 PRIOR LINES OF CHEMOTHERAPY: A PHASE IB STUDY Article Open access 02 January 2025 PHASE 1 DOSE-ESCALATION STUDY EVALUATING THE SAFETY,
PHARMACOKINETICS, AND CLINICAL ACTIVITY OF OBI-3424 IN PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS Article Open access 12 May 2023 AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Centre
Antoine Lacassagne, Nice, France J Santini Authors * J Santini View author publications You can also search for this author inPubMed Google Scholar * G Milano View author publications You
can also search for this author inPubMed Google Scholar * A Thyss View author publications You can also search for this author inPubMed Google Scholar * N Renee View author publications You
can also search for this author inPubMed Google Scholar * P Viens View author publications You can also search for this author inPubMed Google Scholar * P Ayela View author publications You
can also search for this author inPubMed Google Scholar * M Schneider View author publications You can also search for this author inPubMed Google Scholar * F Demard View author publications
You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Santini, J., Milano, G., Thyss, A. _et al._
5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer. _Br J Cancer_ 59, 287–290 (1989). https://doi.org/10.1038/bjc.1989.59
Download citation * Issue Date: 01 February 1989 * DOI: https://doi.org/10.1038/bjc.1989.59 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get
shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative
Trending News
A-levels are only a fiasco. The coming cancer crisis might be a catastrophe | thearticleOlder people who read, watch or listen to the news a little too much sometimes fall into the trap of thinking that they ...
Doctor gives warning to morning coffee drinkersDR MASARAT JILANI HAS WARNED THAT PEOPLE SHOULD AVOID DRINKING COFFEE FIRST THING IN THE MORNING, PARTICULARLY IF THEY H...
Ferguson: rangers star kent will be tempted with leeds moveBarry Ferguson has told Go Radio – as per the Record – that Rangers star Ryan Kent will be tempted with a move to Leeds ...
Real Estate Institute of Tasmania president Tony Collidge says Tasmanian first-time buyers are struggling to find propertiesAdNewsLocal NewsNewsLocal NewsNews HomeNewsSportCommunityTributes & FuneralsClassifiedsExplore TravelEntertainmentLifest...
One ART Regimen Tied to Lower COVID-19 Risk in HIVA certain regimen of antiretroviral therapy (ART) may have contributed to lower COVID-19 incidence and severity among pe...
Latests News
5-fu therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancerABSTRACT This 4 year study reports on a pharmacokinetic study for the widely used regimen of cis-platin plus continuous ...
Lung ventilation and perfusion scintigraphy in the follow-up of repaired congenital diaphragmatic herniaABSTRACT To evaluate the effects of congenital dialphragmatic hemia (CDH) and pulmonary hypoplasia on subsequent lung de...
The simple and quick daily habit proven to reduce risk of early deathA long life free from chronic health problems cannot be guaranteed but an unswerving commitment to healthy lifestyle hab...
Temporomandibular disorders: masticatory myalgia and its managementYou have full access to this article via your institution. Download PDF ARTICLE PDF Authors * W K Solberg View author pu...
Ferrari's sebastian vettel plan as lewis hamilton targets rival's seatFerrari are in the midst of a title-drought stretching back to 2008, when Kimi Raikkonen and Felipe Massa’s efforts secu...